Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial

Cited by (1,000)

Items 301–400 of 1,000

1. QTc Interval Prolongation and Life-Threatening Arrhythmias During Hospitalization in Patients With Coronavirus Disease 2019 (COVID-19): Results From a Multicenter Prospective Registry
   Francesco Santoro, Francesco Monitillo, Pasquale Raimondo, Agostino Lopizzo, Gaetano Brindicci, Michele Gilio, Francesco Musaico, Michele Mazzola, Domenico Vestito, Rossella Di Benedetto et al. · 2020 · Clinical Infectious Diseases
2. Recommendations for treatment of critically ill patients with COVID-19
   Stefan Kluge, Uwe Janssens, Tobias Welte, Steffen Weber‐Carstens, Gereon Schälte, Bernd Salzberger, Petra Gastmeier, Florian Peter Länger, M. Welper, Michael Westhoff et al. · 2020 · Der Anaesthesist
3. Pharmacokinetics-Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: a Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents
   Markus Alexander Zeitlinger, Birgit C. P. Koch, Roger J. M. Brüggemann, Pieter A. J. G. De Cock, Tim Felton, Maya Hites, Jennifer Lê, Sònia Luque, Alasdair P. MacGowan, Deborah J. E. Marriott et al. · 2020 · Clinical Pharmacokinetics
4. Use of amantadine in a patient with SARS‐CoV‐2
   Gonzálo Emiliano Aranda-Abreu, José Dolores Aranda‐Martínez, Ramiro Araújo · 2020 · Journal of Medical Virology
5. Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen
   Andrea Bernardini, Giuseppe Ciconte, Gabriele Negro, Roberto Rondine, Valerio Mecarocci, Tommaso Viva, F. Santini, Carlo De Innocentiis, Luigi Giannelli, Ewa Witkowska et al. · 2020 · International Journal of Cardiology
6. Investigational Treatments for COVID‐19 may Increase Ventricular Arrhythmia Risk Through Drug Interactions
   Meera Varshneya, Itziar Irurzun‐Arana, Chiara Campana, Rafael Dariolli, Amy Gutierrez, Taylor K. Pullinger, Eric A. Sobie · 2020 · CPT Pharmacometrics & Systems Pharmacology
7. Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
   Tzu‐Chuan Ho, Yung-Hsuan Wang, Yi‐Ling Chen, Wan-Chi Tsai, Che‐Hsin Lee, Kuo‐Pin Chuang, Yi‐Ming Arthur Chen, Cheng‐Hui Yuan, Sheng‐Yow Ho, Ming‐Hui Yang et al. · 2021 · Pathogens
8. A retrospective analysis of clinical efficacy of ribavirin in adults hospitalized with severe COVID-19
   Wei‐Jing Gong, Tao Zhou, Sanlan Wu, Jia-Long Ye, Jiaqiang Xu, Fang Zeng, Yuyong Su, Yong Kwon Han, Yongning Lv, Yu Zhang et al. · 2021 · Journal of Infection and Chemotherapy
9. The time to offer treatments for COVID-19
   Binh Ngo, Paul Ellis Marik, Pierre D. Kory, Leland Shapiro, Raphael Thomadsen, Jose I. Iglesias, Stephen Ditmore, Marc Rendell, Joseph Varón, Michael P. Dubé et al. · 2021 · Expert Opinion on Investigational Drugs
10. The in vitro antiviral activity of the anti-hepatitis C virus (HCV) drugs daclatasvir and sofosbuvir against SARS-CoV-2
    Carolina Q. Sacramento, Natalia Fintelman Rodrigues, Jairo Ramos Temerozo, Aline de Paula Dias da Silva, Suelen da Silva Gomes Dias, Carine dos Santos da Silva, André Costa Ferreira, Mayara Mattos, Camila R. R. Pão, Caroline Souza de Freitas et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
11. Classifying COVID-19 positive X-ray using deep learning models
    Iago Richard Rodrigues, Guto Leoni Santos, Djamel Fawzi Hadj Sadok, Patrícia Takako Endo · 2021 · IEEE Latin America Transactions
12. Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine – from HIV-1 infection to COVID-19
    Sara Naghipour, Mahsa Ghodousi, Sara Rahsepar, Sepideh Elyasi · 2020 · Expert Review of Anti-infective Therapy
13. Concentration-dependent mortality of chloroquine in overdose
    James A Watson, Joel Tärning, Richard M. Hoglund, Frédéric Joseph Baud, Bruno Mégarbane, J. L. Clemessy, Nicholas John White · 2020 · eLife
14. Therapeutic Options for COVID-19: A Review
    Rishita Rama Pujari, Mary V Thommana, Brisandi Ruiz Mercedes, Ayna Serwat · 2020 · Cureus
15. COVID‐SAFER : Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults
    Sydney B. Ross, Marnie Goodwin Wilson, Louise Papillon‐Ferland, Sarah Elsayed, Peter E. Wu, Kiran Battu, Sandra Porter, Babak Rashidi, Robyn M Tamblyn, Louise Pilote et al. · 2020 · Journal of the American Geriatrics Society
16. Possible therapeutic agents for COVID-19: a comprehensive review
    Khaled Mosaad Elhusseiny, Fatma Abd‐Elshahed Abd‐Elhay, Mohamed Gomaa Kamel · 2020 · Expert Review of Anti-infective Therapy
17. Coronavirus in human diseases: Mechanisms and advances in clinical treatment
    Panpan Lin, Manni Wang, Yuquan Wei, Tae‐Wan Kim, Xiawei Wei · 2020 · MedComm
18. Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off‐label in the first wave of COVID‐19
    Annie G. Delaunois, Matthew M. Abernathy, Warren D. Anderson, Kylie A. Beattie, Khuram W. Chaudhary, Julie Coulot, Vitalina Gryshkova, Simon Hebeisen, Mark Holbrook, James Kramer et al. · 2021 · Clinical and Translational Science
19. Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity
    Guillaume Hache, Jean‐Marc Rolain, Philippe Gautret, Jean‐Claude Deharo, Philippe Brouqui, Didier Raoult, Stéphane Honoré · 2021 · Microbial Drug Resistance
20. Strategies to deal with the COVID-19 pandemic
    Paulo Nadanovsky, Ana Paula Pires dos Santos · 2020 · Brazilian Oral Research
21. Tratamiento farmacológico de la COVID-19: revisión narrativa de los Grupos de Trabajo de Enfermedades Infecciosas y Sepsis (GTEIS) y del Grupo de Trabajo de Transfusiones Hemoderivados (GTTH)
    Emili Dı́az, R. Amézaga Menéndez, Pablo Vidal, María Gero Escapa, Borja Suberviola, Ainhoa Serrano, Pilar Marcos-Neira, Manuel Quintana‐Díaz, M. Catalán González · 2020 · Medicina Intensiva
22. Publications and retracted articles of COVID-19 pharmacotherapy-related research: A systematic review
    Ayman Ahmed El-Menyar, Ahammed Abdulla Mekkodathil, Mohammad Asim, Rafael J. Consunji, Sandro Baleotti Rizoli, Ahmed Abdel‐Aziz Bahey, Hassan Ali Saoud Al-Thani · 2021 · Science Progress
23. Changes in sexual functions and habits of healthcare workers during the ongoing COVID-19 outbreak: a cross-sectional survey study
    Ahmet Güzel, Ayşe Döndü · 2021 · Irish Journal of Medical Science (1971 -)
24. Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis
    Tawanda Chivese, Omran A. H. Musa, George Hindy, Noor Al-Wattary, Saif M. Badran, Nada Soliman, Ahmed Tarek Aboughalia, Joshua T. Matizanadzo, Mohamed M. Emara, Lukman Thalib et al. · 2021 · Travel Medicine and Infectious Disease
25. Antivirals and the Potential Benefits of Orally Inhaled Drug Administration in COVID-19 Treatment
    Gokben Sahin, Özlem Akbal Dağıstan, Meltem Culha, Aybige Erturk, Nur Sena Basarir, Serap Sancar, Ayca Yıldız-Peköz · 2022 · Journal of Pharmaceutical Sciences
26. A Pharmacovigilance Study of Hydroxychloroquine Cardiac Safety Profile: Potential Implication in COVID-19 Mitigation
    Anand Prakash Singh, Sultan Tousif, Prachi Umbarkar, Hind Lal · 2020 · Journal of Clinical Medicine
27. Drug treatment of coronavirus disease 2019 (COVID-19) in China.
    Zhe Jin, Jing-Yi Liu, Rang Feng, Lu Ji, Zi-Li Jin, Haibo Li · 2020 · European Journal of Pharmacology
28. Systematic review and meta‐analysis of effectiveness of treatment options against SARS‐CoV‐2 infection
    Viveksandeep Thoguluva Chandrasekar, Bhanu Prasad Venkatesulu, Harsh K. Patel, Marco Spadaccini, Jacob J. Manteuffel, Mayur S. Ramesh · 2020 · Journal of Medical Virology
29. The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse
    Taylor Morrisette, Thomas P. Lodise, Marc H. Scheetz, Srijib Goswami, Jason M. Pogue, Michael Joseph Rybak · 2020 · Infectious Diseases and Therapy
30. Empfehlungen zur intensivmedizinischen Therapie von Patienten mit COVID-19 – 3. Version
    Stefan Kluge, Uwe Janssens, Tobias Welte, Steffen Weber‐Carstens, Gereon Schälte, Bernd Salzberger, Petra Gastmeier, Florian Peter Länger, Martin Wepler, Michael Westhoff et al. · 2020 · Der Anaesthesist
31. Incidence and treatment of arrhythmias secondary to coronavirus infection in humans: A systematic review
    Michael M. Malaty, Tahrima Kayes, Anjalee Thanuja Amarasekera, Matthew H. Kodsi, Chandini Raina MacIntyre, Timothy C. Tan · 2020 · European Journal of Clinical Investigation
32. Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety
    Michael Takla, Kamalan Jeevaratnam · 2020 · Saudi Pharmaceutical Journal
33. Experimental Pharmacotherapy for COVID-19: The Latest Advances
    Pasquale Pagliano, Giuliana Scarpati, Carmine Sellitto, Valeria Conti, Anna Maria Spera, Tiziana Ascione, Ornella Piazza, Amelia Filippelli · 2021 · Journal of Experimental Pharmacology
34. Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets
    Isabella Romeo, Francesco Mesiti, Antonio Lupia, Stefano Alcaro · 2021 · Molecules
35. Cardiotoxic Potential of Hydroxychloroquine, Chloroquine and Azithromycin in Adult Human Primary Cardiomyocytes
    Pierre Jordaan, Berengere M Dumotier, Martin Traebert, Paul E Miller, Andre Ghetti, László Urbán, Najah Abi‐Gerges · 2021 · Toxicological Sciences
36. COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence
    F. Idalsoaga, G. Ayares, J. Arab, L. Díaz · 2021 · Journal of Clinical and Translational Hepatology
37. Systems pharmacology-based drug discovery and active mechanism of natural products for coronavirus pneumonia (COVID-19): An example using flavonoids
    Bin Wang, Yan Ding, Penghui Zhao, Wei Li, Ming Li, Jingbo Zhu, Shuhong Ye · 2022 · Computers in Biology and Medicine
38. COVID‐19 treatment in patients with comorbidities: Awareness of drug‐drug interactions
    David J. Back, Catia Marzolini, Daryl Hodge, Fiona Marra, Alison Boyle, Sara Gibbons, David Marinus Burger, Saye Khoo · 2020 · British Journal of Clinical Pharmacology
39. Chloroquine dosage regimens in patients with COVID-19: Safety risks and optimization using simulations
    Vangelis D. Karalis, George Ismailos, Eleni Karatza · 2020 · Safety Science
40. Coronavirus disease 2019 (COVID-19): latest developments in potential treatments
    Kam‐Lun Ellis Hon, Karen Ka Yan Leung, Alexander K. C. Leung, Su Yun Qian, Vivian Pui Ying Chan, Patrick Ip, Ian Chi Kei Wong · 2020 · Drugs in Context
41. Beta-Adrenergic Receptor Stimulation Modulates the Cellular Proarrhythmic Effects of Chloroquine and Azithromycin
    Henry Sutanto, Jordi Heijman · 2020 · Frontiers in Physiology
42. Antiviral Agent Therapy Optimization in Special Populations of COVID-19 Patients
    Lu Li, Xiaojuan Wang, Rongrong Wang, Yunzhen Hu, Saiping Jiang, Xiaoyang Lu · 2020 · Drug Design Development and Therapy
43. Drug repurposing for the treatment of COVID-19: Pharmacological aspects and synthetic approaches
    Pedro N. Batalha, Luana da Silva Magalhães Forezi, Carolina G. S. Lima, Fernanda P. Pauli, Fernanda da Costa Santos Boechat, Maria Cecília B. V. de Souza, Anna C. Cunha, Vı́tor F. Ferreira, Fernando de Carvalho da Silva · 2020 · Bioorganic Chemistry
44. Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of in vitro, in vivo, and clinical trials
    Young Joo Han, Keum Hwa Lee, Sojung Yoon, Seoung Wan Nam, Seohyun Ryu, Dawon Seong, Jae‐Seok Kim, Jun Young Lee, Jae Won Yang, Jinhee Lee et al. · 2020 · Theranostics
45. Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs
    Nathalie Vernaz, Thomas Agoritsas, Alexandra Calmy, Angèle Gayet‐Ageron, Gabriel Gold, Arnaud Perrier, Fabienne Picard, Virginie Prendki, Jean‐Luc Reny, Caroline Flora Samer et al. · 2020 · Swiss Medical Weekly
46. Clinical Management of COVID-19: A Review of Pharmacological Treatment Options
    Ashli Heustess, Melissa Allard, Dorothea K. Thompson, Pius S. Fasinu · 2021 · Pharmaceuticals
47. COVID‐19 und Immunregulation – von grundlegenden und translationalen Aspekten zu klinischen Implikationen
    Michael Peter Schön, Carola Berking, Tilo Biedermann, Timo Buhl, Luise Erpenbeck, Kilian Eyerich, Stefanie Eyerich, Kamran Ghoreschi, Matthias Goebeler, Ralf Joachim Ludwig et al. · 2020 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
48. Chloroquine and hydroxychloroquine for COVID‐19: Perspectives on their failure in repurposing
    Rashmi R. Shah · 2020 · Journal of Clinical Pharmacy and Therapeutics
49. Natural Plant Products: A Less Focused Aspect for the COVID-19 Viral Outbreak
    Anamika Pandey, Mohd. Kamran Khan, Mehmet Hamurcu, Sait Gezgіn · 2020 · Frontiers in Plant Science
50. Hydroxychloroquine for the treatment and prophylaxis of COVID-19: The journey so far and the road ahead
    Harmanjit Singh, Prerna Chauhan, Ashish Kumar Kakkar · 2020 · European Journal of Pharmacology
51. Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial
    Sylvain Lother, Mahsa Abassi, Alyssa Agostinis, Ananta Shrikant Bangdiwala, Matthew Pellan Cheng, Glen Drobot, Nicole Wyman Engen, Kathy Huppler Hullsiek, Lauren E. Kelly, Todd Campbell Lee et al. · 2020 · Canadian Journal of Anesthesia/Journal canadien d anesthésie
52. Cardiac rehabilitation activities during the COVID-19 pandemic in Italy. Position Paper of the AICPR (Italian Association of Clinical Cardiology, Prevention and Rehabilitation)
    Gian Francesco Mureddu, Marco Ambrosetti, Elio Venturini, Maria Teresa La Rovere, Antonio Mazza, Roberto F.E. Pedretti, Filippo Maria Sarullo, Francesco Fattirolli, Pompilio Massimo Faggiano, Francesco Giallauria et al. · 2020 · Monaldi Archives for Chest Disease
53. The saudi critical care society clinical practice guidelines on the management of COVID-19 patients in the intensive care unit
    Waleed A. Alhazzani, Faisal A. Al-Suwaidan, Zohair Ahmed Al Aseri, Abbas Saleh Al Mutair, Ghassan Alghamdi, AliA Rabaan, Mohmmed Algamdi, Ahmed F. Alohali, AyedY Asiri, MohammedS Alshahrani et al. · 2020 · Saudi Critical Care Journal
54. Hydroxychloroquine use in COVID-19: is the risk of cardiovascular toxicity justified?
    Alex Stevenson, Ali Zuhair Kirresh, Samuel Conway, Laura White, Mahmood Ahmad, Callum D. Little · 2020 · Open Heart
55. Extracorporeal Treatment for Chloroquine, Hydroxychloroquine, and Quinine Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup
    Ingrid Berling, Joshua D. King, Greene Shepherd, Robert S. Hoffman, Badria Alhatali, Valéry Lavergne, Darren M. Roberts, Sophie Gosselin, Gabrielle Wilson, Thomas D. Nolin et al. · 2020 · Journal of the American Society of Nephrology
56. Targeting the SARS-CoV2 nucleocapsid protein for potential therapeutics using immuno-informatics and structure-based drug discovery techniques
    Alexander Kwarteng, Ebenezer Asiedu, Samuel Asamoah Sakyi, Samuel Opoku Asiedu · 2020 · Biomedicine & Pharmacotherapy
57. Missing clinical trial data: the evidence gap in primary data for potential COVID-19 drugs
    Florence Rodgers, Toby Pepperrell, Sarai Keestra, Victoria Pilkington · 2021 · Trials
58. Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis
    Jogender Kumar, Siddharth Jain, Jitendra Kumar Meena, Arushi Yadav · 2021 · Journal of Infection and Chemotherapy
59. Role of biomaterials in the diagnosis, prevention, treatment, and study of corona virus disease 2019 (COVID-19)
    Yavuz Nuri Ertaş, Mahboobeh Mahmoodi, Fahimeh Shahabipour, Vahid Jahed, Sibel Emi̇r Di̇ltemi̇z, Rumeysa Tutar, Nureddin A. Ashammakhi · 2021 · Emergent Materials
60. Human coronaviruses and therapeutic drug discovery
    Langui Song, Qing-Xing Xie, Huilin Lao, Zhiyue Lv · 2021 · Infectious Diseases of Poverty
61. Progress and pitfalls of a year of drug repurposing screens against COVID-19
    Julien Sourimant, Megha Aggarwal, Richard Karl Plemper · 2021 · Current Opinion in Virology
62. G6PD distribution in sub-Saharan Africa and potential risks of using chloroquine/hydroxychloroquine based treatments for COVID-19
    Jorge da Rocha, Houcemeddine Othman, Caroline T. Tiemessen, Gerrit Botha, Michèle Ramsay, Collen Mutowembwa Masimirembwa, Clement Adebamowo, Ananyo Choudhury, Jean‐Tristan Brandenburg, Mogomotsi Matshaba et al. · 2021 · The Pharmacogenomics Journal
63. Electrophysiological and Proarrhythmic Effects of Hydroxychloroquine Challenge in Guinea-Pig Hearts
    Gongxin Wang, Chieh‐Ju Lu, Andrew W. Trafford, Xiaohui Tian, Hannali M Flores, Piotr Maj, Kevin Zhang, Yanhong Niu, Luxi Wang, Yimei Du et al. · 2021 · ACS Pharmacology & Translational Science
64. Efficacy of Chloroquine and Hydroxychloroquine for the Treatment of Hospitalized COVID-19 Patients: A Meta-Analysis
    Jiawen Deng, Fangwen Zhou, Kiyan Heybati, Saif Hassan Ali, Qi Zuo, Wenteng Hou, Thanansayan Dhivagaran, Harikrishnaa Ba Ramaraju, Oswin Chang, Chi Yi Wong et al. · 2021 · Future Virology
65. Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants
    Hanjun Zhao, Xinjie Meng, Zheng Peng, Hoiyan Lam, Chuyuan Zhang, Xinxin Zhou, Jasper Fuk‐Woo Chan, Richard Yi Tsun Kao, Kelvin Kai‐Wang To, Kwok‐Yung Yuen · 2022 · Emerging Microbes & Infections
66. COVID-19: Pharmacology and kinetics of viral clearance
    Nicola Farina, Giuseppe Alvise Ramirez, Rebecca DE LORENZO, Luigi di Filippo, Caterina Conte, Fabio Ciceri, Angelo Andrea Manfredi, Patrizia Querini Rovere · 2020 · Pharmacological Research
67. Kakkonto, shosaikoto, Platycodon grandiflorum root, and gypsum (a Japanese original combination drug known as saikatsugekito): Pharmacological review of its activity against viral infections and respiratory inflammatory conditions and a discussion of its applications to COVID ‐19
    Ryutaro Arita, Rie Ono, Natsumi Saito, Shin Takayama, Takao Namiki, Takashi Ito, Tadashi Ishii · 2020 · Traditional & Kampo Medicine
68. COVID-19 Management and Arrhythmia: Risks and Challenges for Clinicians Treating Patients Affected by SARS-CoV-2
    Alexander Carpenter, Owen J. Chambers, Aziza El Harchi, Richard C. Bond, Oliver Hanington, Stephen C. Harmer, Jules C. Hancox, Andrew F. James · 2020 · Frontiers in Cardiovascular Medicine
69. Pharmacokinetic Basis of the Hydroxychloroquine Response in COVID-19: Implications for Therapy and Prevention
    Mohammad Tarek, Andrea Savarino · 2020 · European Journal of Drug Metabolism and Pharmacokinetics
70. Hydroxychloroquine and Azithromycin to Treat Patients With COVID‐19: Both Friends and Foes?
    Bruno Mégarbane, Jean‐Michel Scherrmann · 2020 · The Journal of Clinical Pharmacology
71. Fatal arrhythmias: Another reason why doctors remain cautious about chloroquine/hydroxychloroquine for treating COVID-19
    Ilija Uzelac, Shahriar Iravanian, Hiroshi Ashikaga, Neal Kumar Bhatia, Conner Herndon, Abouzar Kaboudian, James C. Gumbart, Elizabeth M. Cherry, Flavio H. Fenton · 2020 · Heart Rhythm
72. Research Progress on Repositioning Drugs and Specific Therapeutic Drugs for SARS-CoV-2
    Shiyong Fan, Dian Xiao, Yanming Wang, Lianqi Liu, Xinbo Zhou, Wu Zhong · 2020 · Future Medicinal Chemistry
73. Knowledge levels among elderly people with Diabetes Mellitus concerning COVID-19: an educational intervention via a teleservice
    Bartolomeu Fagundes de Lima Filho, Nathalia Priscilla Oliveira Silva Bessa, Ana Clara Teixeira Fernandes, Íkaro Felipe da Silva Patrício, Nadja de Oliveira Alves, Fabrícia Azevêdo da Costa Cavalcanti · 2020 · Acta Diabetologica
74. Emerging Therapeutic Modalities against COVID-19
    Shipra Malik, Anisha Gupta, Xiao‐bo Zhong, Theodore P. Rasmussen, José Enrique Manautou, Raman Bahal · 2020 · Pharmaceuticals
75. COVID-19 en Latinoamérica: una revisión sistemática de la literatura y análisis bibliométrico
    David Alberto Forero-Peña, Fhabián S. Carrión‐Nessi, Natasha A. Camejo‐Ávila, Magda Julieth Forero-Peña · 2020 · Revista de Salud Pública
76. Multi-organ damage by covid-19: congestive (cardio-pulmonary) heart failure, and blood-heart barrier leakage
    Suresh C. Tyagi, Mahavir Singh · 2021 · Molecular and Cellular Biochemistry
77. Comprehensive Consensus Analysis of SARS-CoV-2 Drug Repurposing Campaigns
    Hazem Mslati, Francesco Gentile, Carl F. Perez, Artem R Cherkasov · 2021 · Journal of Chemical Information and Modeling
78. Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial
    Berta Grau-Pujol, Daniel Camprubí-Ferrer, Helena Martí-Soler, Marc Fernández-Pardos, Clara Carreras‐Abad, María Velasco‐de Andrés, Elisabet Ferrer, Magdalena Muelas‐Fernandez, Sophie Jullien, Giuseppe Barilaro et al. · 2021 · Trials
79. Metabolomic Profiling of Plasma Reveals Differential Disease Severity Markers in COVID-19 Patients
    Lucas Barbosa Oliveira, Victor Irungu Mwangi, Marco Aurélio Sartim, Jeany Delafiori, Geovana Manzan Sales, Arthur Noin de Oliveira, Estela Natacha Brandt Busanello, Fernando Val, Mariana Simão Xavier, Fábio Trindade Maranhão Costa et al. · 2022 · Frontiers in Microbiology
80. Finding a chink in the armor: Update, limitations, and challenges toward successful antivirals against flaviviruses
    Thamil Vaani Komarasamy, Nur Amelia Azreen Adnan, William James, Vinod R. M. T. Balasubramaniam · 2022 · PLoS neglected tropical diseases
81. Identification and Development of Therapeutics for COVID-19
    Halie M. Rando, Nils Wellhausen, Soumita Ghosh, Lee, Alexandra J, Anna Ada Dattoli, Fengling Hu, James Brian Byrd, Diane N. Rafizadeh, Yanjun Qi, Yuchen Sun et al. · 2021 · Lund University Publications (Lund University)
82. A review on drug repurposing in COVID-19: from antiviral drugs to herbal alternatives
    Abas Sezer, Mervisa Halilović-Alihodžić, Annissa Rachel Vanwieren, Adna Smajkan, Amina Karić, Husein Djedović, Jasmin Šutković · 2022 · Journal of Genetic Engineering and Biotechnology
83. Acute chloroquine poisoning: A comprehensive experimental toxicology assessment of the role of diazepam
    Dyfrig Arwyn Hughes · 2020 · British Journal of Pharmacology
84. Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients—a perspective
    Lennart L G Hammarström, Hassan Abolhassani, Fausto Baldanti, Harold Marcotte, Qiang Pan‐Hammarström · 2020 · Journal of Allergy and Clinical Immunology
85. Health and Economy in COVID-19 Era: A Plan for Reconstituting Long-Term Economic Security
    Mary Beth Allen, Mehdi Seyed Mirsaeidi · 2020 · Frontiers in Public Health
86. Systematic review and meta-analysis of the effectiveness and safety of hydroxychloroquine in treating COVID-19 patients
    Tzu-Han Yang, Chian‐Ying Chou, Yifan Yang, Chian‐Shiu Chien, Aliaksandr A. Yarmishyn, Tzu-Ying Yang, Cheng-Hsuan Liu, Kao-Jung Chang, Yi‐Ping Yang, Yuh‐Lih Chang · 2020 · Journal of the Chinese Medical Association
87. Management of Pediatric Kidney Transplant Patients During the COVID-19 Pandemic: Guidance From the Canadian Society of Transplantation Pediatric Group
    Chia Wei Teoh, Marie‐Michèle Gaudreault‐Tremblay, Tom David Blydt‐Hansen, Aviva M. Goldberg, Steven Arora, Janusz Feber, Valerie Langlois, Michelle Ruhl, Véronique Phan, Catherine Morgan et al. · 2020 · Canadian Journal of Kidney Health and Disease
88. The growing complexity of COVID-19 drug and vaccine candidates: challenges and critical transitions
    Mohammad Hossain Shariare, Md. Anowar Khasru Parvez, George Albert Karikas, Mohsin Kazi · 2020 · Journal of Infection and Public Health
89. iDMer: an integrative and mechanism-driven response system for identifying compound interventions for sudden virus outbreak
    Zhiting Wei, Yuli Gao, Fangliangzi Meng, Xin Chen, Yukang Gong, Chenyu Zhu, Bin Ju, Chao Zhang, Zhongmin Liu, Qi Liu · 2020 · Briefings in Bioinformatics
90. Efficacy and safety of chloroquine and hydroxychloroquine for treatment of COVID-19 patients-a systematic review and meta-analysis of randomized controlled trials.
    Paul Eze, Kenechukwu N. Mezue, Chidozie U Nduka, Ijeoma Obianyo, Obiora Egbuche · 2021 · PubMed Central
91. Novel corona virus (COVID-19); Global efforts and effective investigational medicines: A review
    Madhusudan Goyal, Nisha Tewatia, Hemlata Vashisht, Reena Jain, Sudershan Kumar · 2021 · Journal of Infection and Public Health
92. An Overview on the Epidemiology and Immunology of COVID-19
    Maryam Meskini, Mina Rezghi Rami, Parang Maroofi, Soumya Bikash Ghosh, Seyed Davar Siadat, Mojgan Sheikhpour · 2021 · Journal of Infection and Public Health
93. Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives
    Weiqi Yao, Lei Shi, Yun Zhang, Haibo Dong, Yu Zhang · 2022 · Stem Cell Research & Therapy
94. CLINICAL FEATURES, DIAGNOSIS AND TREATMENT OF COVID-19
    J Ali, Qurban Ali, MM Hafeez, Arif Malik · 2020 · Biological and Clinical Sciences Research Journal
95. Antimalarials as Antivirals for COVID-19: Believe it or Not!
    Biplab Kumar Saha, Alyssa Bonnier, Woon Hean Chong · 2020 · The American Journal of the Medical Sciences
96. Efficacy and safety of transfusing plasma from COVID-19 survivors to COVID-19 victims with severe illness. A double-blinded controlled preliminary study
    Ossama Hamdy Salman, Hatem Saber Mohamed · 2020 · Egyptian Journal of Anaesthesia
97. Drug repurposing: new strategies for addressing COVID-19 outbreak
    Pravin K. Shende, Bhakti Khanolkar, Rajesh Gaud · 2020 · Expert Review of Anti-infective Therapy
98. SARS-CoV-2 therapeutics: how far do we stand from a remedy?
    Anurag Kumar Singh, Vandana Gupta · 2021 · Pharmacological Reports
99. Reviving chloroquine for anti-SARS-CoV-2 treatment with cucurbit[7]uril-based supramolecular formulation
    Cheryl H. T. Kwong, Jingfang Mu, Shengke Li, Yaohui Fang, Qianyun Liu, Xiangjun Zhang, Hiotong Kam, Simon Ming‐Yuen Lee, Yu Zheng Chen, Fēi Dèng et al. · 2021 · Chinese Chemical Letters
100. Quantifying arrhythmic long QT effects of hydroxychloroquine and azithromycin with whole-heart optical mapping and simulations
     Ilija Uzelac, Abouzar Kaboudian, Shahriar Iravanian, Jimena Gabriela Siles Paredes, James C. Gumbart, Hiroshi Ashikaga, Neal Kumar Bhatia, Robert F. Gilmour, Elizabeth M. Cherry, Flavio H. Fenton · 2021 · Heart Rhythm O2